Xcene Research

Orphan Drugs

Orphan Drugs: Why the Designation?

Orphan drugs are medicinal products intended for the diagnosis, prevention, or treatment of life-threatening or very serious diseases or disorders that are rare. A disease or disorder is defined as rare when it affects less than 1 in 2,000 citizens, some rare diseases include Moebius syndrome, Stoneman syndrome, alkaptonuria. These drugs are called “orphans” because, […]

Orphan Drugs: Why the Designation? Read More »

Rare Diseases_Tristan_SickleCellDisease

Rare Diseases

A rare disease is any disease that affects a small percentage of people in a population. While no universal ratio exists, many countries or regions identify the prevalence of such conditions based on their environment. For instance in the European Union (EU), a disease is classified as a rare disease if it affects fewer than

Rare Diseases Read More »

Clinical Trials v Clinical Research

Clinical Trials vs. Clinical Research: What’s to Know?

“Wherever the art of medicine is loved, there is also a love of humanity” – Hippocrates When new drugs, vaccines, and medical devices are developed and marketed, one of the most important things to address is safety—the tracking of adverse events related to the usage of medicinal products.  But what goes on behind the scenes

Clinical Trials vs. Clinical Research: What’s to Know? Read More »

Sickle Cell Disease SCD Management

Sickle Cell Disease Management: Past and Future

Sickle Cell Disease (SCD) is a hereditary disorder of hemoglobin. It is characterized by severe hemolytic anemia with a range of clinical manifestations such as anemia, periodic episodes of pain (pain crises), frequent infections, and delayed growth or puberty among other symptoms. More people in Africa suffer from SCD than in other parts of the

Sickle Cell Disease Management: Past and Future Read More »

Impact Africa Summit 2020

The Impact Africa Summit (IAS) 2020

The Impact Africa Summit (IAS) a brainchild of Nigeria’s foremost contract research organization is designed to initiate strategic interactions and forge collaborations for excellence within the clinical research industry for Africa. The goal of the Impact Africa Summit is to build a network of industry experts and stakeholders to help achieve sustainable capacity for pharmaceutical

The Impact Africa Summit (IAS) 2020 Read More »

Wearable to detect COVID-19 Symptoms

Could Wearables Detect COVID-19 Before Symptoms Appear?

Early research findings from Fitbit show that physiological signs of disease can be detected by wearable devices simultaneously with individuals reporting the onset of COVID-19 symptoms, and in some cases even before Fitbit has released findings from a recent study showing that its wearable device can detect nearly 50 percent of COVID-19 cases one day

Could Wearables Detect COVID-19 Before Symptoms Appear? Read More »